TCF7L2 involvement in estradiol- and progesterone-modulated islet and hepatic glucose homeostasis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Dong, Fengqin ^a   Ling, Qi ^b   Ye, Dan ^a   Zhang, Zhe ^a   Shu, Jing ^c   Chen, Guoping ^a   Fei, Yang ^d   Li, Chengjiang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d Fuyang Renmin Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GLUCOSE; PROGESTERONE; TCF7L2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR 7 LIKE 2;

ANIMAL; CELL LINE; HOMEOSTASIS; HUMAN; LIVER; METABOLISM; MOUSE; PANCREAS ISLET;

ANIMALS; CELL LINE; ESTRADIOL; GLUCOSE; HOMEOSTASIS; HUMANS; ISLETS OF LANGERHANS; LIVER; MICE; PROGESTERONE; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 84964643012     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24859     Document Type: Article

References (39)

1. Tutino, G. E. et al. Diabetes and pregnancy: perspectives from Asia. Diabet Med 31, 302-318 (2014).
2. Ferrara, A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 30 Suppl 2, S141-146 (2007).
3. Liu, L., Hong, Z. & Zhang, L. Associations of prepregnancy body mass index and gestational weight gain with pregnancy outcomes in nulliparous women delivering single live babies. Sci Rep 5, 12863 (2015).
4. Nadal, A., Alonso-Magdalena, P., Soriano, S., Ropero, A. B. & Quesada, I. The role of oestrogens in the adaptation of islets to insulin resistance. J Physiol 587, 5031-5037 (2009).
5. Camporez, J. P. et al. Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance. Endocrinology 154 (2013).
6. Nieuwenhuizen, A. G. et al. Progesterone stimulates pancreatic cell proliferation in vivo. Eur J Endocrinol 140, 256-263 (1999).
7. Angueira, A. R. et al. New insights into gestational glucose metabolism: lessons learned from 21st century approaches. Diabetes 64, 327-334 (2015).
8. Zhang, C. et al. Genetic variants and the risk of gestational diabetes mellitus: a systematic review. Hum Reprod Update 19, 376-390 (2013).
9. Zhang, Y., Sun, C. M., Hu, X. Q. & Zhao, Y. Relationship between melatonin receptor 1B and insulin receptor substrate 1 polymorphisms with gestational diabetes mellitus: a systematic review and meta-analysis. Sci Rep 4, 6113 (2014).
10. Zhou, Y. et al. TCF7L2 is a master regulator of insulin production and processing. Hum Mol Genet 23, 6419-6431 (2014).
11. Wagner, R. et al. Clinical and non-targeted metabolomic profiling of homozygous carriers of Transcription Factor 7-like 2 variant rs7903146. Sci Rep 4, 5296 (2014).
12. Takamoto, I. et al. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass. Diabetologia 57, 542-553 (2014).
13. Neve, B. et al. Alternative human liver transcripts of TCF7L2 bind to the gluconeogenesis regulator HNF4alpha at the protein level. Diabetologia 57, 785-796 (2014).
14. Boj, S. F. et al. Diabetes risk gene and Wnt effector Tcf7l2/TCF4 controls hepatic response to perinatal and adult metabolic demand. Cell 151, 1595-1607 (2012).
15. Oh, K. J. et al. TCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in the liver. Plos Genet 8, e1002986 (2012).
16. Ip, W. et al. Liver-specific Expression of Dominant Negative Transcription Factor 7-like 2 Causes Progressive Impairment in Glucose Homeostasis. Diabetes, 64, 1923-1932 (2015).
17. Ling, Q. et al. Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c. J Exp Clin Cancer Res 30, 66 (2011).
18. Sutter-Dub, M. T. Rapid non-genomic and genomic responses to progestogens, estrogens, and glucocorticoids in the endocrine pancreatic B cell, the adipocyte and other cell types. Steroids 67, 77-93 (2002).
19. Picard, F. et al. Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation. Proc Natl Acad Sci USA 99, 15644-15648 (2002).
20. Zhou, R. et al. Blockage of progesterone receptor effectively protects pancreatic islet beta cell viability. Steroids 78, 987-995 (2013).
21. Nunes, V. A. et al. Progesterone induces apoptosis of insulin-secreting cells: insights into the molecular mechanism. J Endocrinol 221, 273-284 (2014).
22. Pedersen, S. H., Nielsen, L. B., Mortensen, A., Nilas, L. & Ottesen, B. Progestins oppose the effects of estradiol on the endothelin-1 receptor type B in coronary arteries from ovariectomized hyperlipidemic rabbits. Menopause 15, 503-510 (2008).
23. Alonso-Magdalena, P. et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. Plos One 3, e2069 (2008).
24. Le May, C. et al. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci USA 103, 9232-9237 (2006).
25. Ahangarpour, A., Heidari, H., Mard, S. A., Hashemitabar, M. & Khodadadi, A. Progesterone and cilostazol protect mice pancreatic islets from oxidative stress induced by hydrogen peroxide. Iran J Pharm Res 13, 937-944 (2014).
26. Straub, S. G., Sharp, G. W., Meglasson, M. D. & De Souza, C. J. Progesterone inhibits insulin secretion by a membrane delimited, non-genomic action. Biosci Rep 21, 653-666 (2001).
27. Basile, K. J., Guy, V. C., Schwartz, S. & Grant, S. F. Overlap of genetic susceptibility to type 1 diabetes, type 2 diabetes, and latent autoimmune diabetes in adults. Curr Diab Rep 14, 550 (2014).
28. Ling, Q. et al. Impacts of TCF7L2 gene polymorphisms on the susceptibility of hepatogenous diabetes and hepatocellular carcinoma in cirrhotic patients. Gene 522, 214-218 (2013).
29. Ling, Q. et al. Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population. J Hepatol 58, 271-277 (2013).
30. Lukacs, K. et al. The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: a meta-analysis and an individual study. Diabetologia 55, 689-693 (2012).
31. Itagaki, T. et al. Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells. Gut 54, 1782-1789 (2005).
32. Cheng, X. et al. Effects of estradiol and progesterone on tumor necrosis factor alpha-induced apoptosis in human hepatoma HuH-7 cells. Life Sci 79, 1988-1994 (2006).
33. Jelenik, T. & Roden, M. How estrogens prevent from lipid-induced insulin resistance. Endocrinology 154, 989-992 (2013).
34. Piccinato, C. A., Rosa, G. J., N'Jai, A. U., Jefcoate, C. R. & Wiltbank, M. C. Estradiol and progesterone exhibit similar patterns of hepatic gene expression regulation in the bovine model. Plos One 8, e73552 (2013).
35. Jiao, P., Feng, B., Li, Y., He, Q. & Xu, H. Hepatic ERK activity plays a role in energy metabolism. Mol Cell Endocrinol 375, 157-166 (2013).
36. Norton, L. et al. Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism. Diabetologia 54, 3132-3142 (2011).
37. Norton, L. et al. The mechanisms of genome-wide target gene regulation by TCF7L2 in liver cells. Nucleic Acids Res 42, 13646-13661 (2014).
38. Root-Bernstein, R., Podufaly, A. & Dillon, P. F. Estradiol Binds to Insulin and Insulin Receptor Decreasing Insulin Binding in vitro. Front Endocrinol (Lausanne) 5, 118 (2014).
39. Sharma, G. & Prossnitz, E. R. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. Endocrinology 152, 3030-3039 (2011).